Vaxfab Enterprises Limited carries a market capitalization of 505.43M, placing it among publicly traded companies globally. Its enterprise value stands at 873.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 505.43M |
| Enterprise Value | 873.64M |
Vaxfab Enterprises Limited currently has 20.87M shares outstanding.
| Shares Outstanding | 20.87M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Vaxfab Enterprises Limited trades at a trailing price-to-earnings ratio of 33.09. The price-to-sales ratio is 0.35, and the price-to-book ratio stands at 1.15.
| PE Ratio | 33.09 |
| PS Ratio | 0.35 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 1.47 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Vaxfab Enterprises Limited trades at an EV/EBITDA multiple of 35.71 and an EV/FCF ratio of 106,451.53. The EV/Sales ratio of 0.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 35.71 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.67 |
| EV / EBITDA | 35.71 |
| EV / EBIT | 35.71 |
| EV / FCF | 106,451.53 |
Vaxfab Enterprises Limited maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 101.65, indicating elevated leverage, while an interest coverage ratio of -21,223.00 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.05 |
| Quick Ratio | 0.02 |
| Debt / Equity | 101.65 |
| Debt / EBITDA | -5.21 |
| Interest Coverage | -21,223.00 |
| Return on Equity (ROE) | -12.74 |
| Return on Assets (ROA) | -1.87 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -5.58 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.70 |
Over the trailing twelve months, Vaxfab Enterprises Limited has paid 15.15M in income taxes, reflecting an effective tax rate of 67.18.
| Income Tax | 15.15M |
| Effective Tax Rate | 67.18 |
Vaxfab Enterprises Limited's stock has gained approximately 241.48695% over the past 52 weeks. The 50-day moving average sits at 55.43, while the 200-day moving average is 43.98.
| Beta (5Y) | N/A |
| 52-Week Price Change | 241.48695% |
| 50-Day Moving Average | 55.43 |
| 200-Day Moving Average | 43.98 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Vaxfab Enterprises Limited generated 1.31B in revenue and converted that into -29.55M in net income, yielding earnings per share of -2.57. EBITDA reached -84.89M, while operating income came in at -84.89M.
| Revenue | 1.31B |
| Gross Profit | -45.32M |
| Operating Income | -84.89M |
| Pretax Income | -14.40M |
| Net Income | -29.55M |
| EBITDA | -84.89M |
| EBIT | -84.89M |
| Earnings Per Share (EPS) | -2.57 |
Vaxfab Enterprises Limited holds 26.24M in cash and equivalents against 442.34M in total debt, resulting in a net debt position of 416.09M. Total book value stands at 400.94M, with working capital of 83.95M providing operational flexibility.
| Cash & Cash Equivalents | 26.24M |
| Total Debt | 442.34M |
| Net Debt | 416.09M |
| Equity (Book Value) | 400.94M |
| Book Value Per Share | 34.81 |
| Working Capital | 83.95M |
Vaxfab Enterprises Limited operates with a gross margin of -3.45, reflecting its pricing power and cost economics. The operating margin of -6.47 and net profit margin of -2.25 provide insight into operational efficiency.
| Gross Margin | -3.45 |
| Operating Margin | -6.47 |
| Pretax Margin | -1.10 |
| Profit Margin | -2.25 |
| EBITDA Margin | -6.47 |
Vaxfab Enterprises Limited's most recent stock split took place on January 3, 2023 with a 125:251 split ratio.
| Last Split Date | 1/3/2023 |
| Split Ratio | 125:251 |
Vaxfab Enterprises Limited posts an Altman Z-Score of 0.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.76 |